Form 4: Executive Acquires Shares and Options in PROCEPT BioRobotics Corp

Hisham Shiblaq, EVP and Chief Commercial Officer of PROCEPT BioRobotics Corp, reports acquisition of common stock and stock options.

Summary

• On March 3, 2025, Hisham Shiblaq, the EVP and Chief Commercial Officer of PROCEPT BioRobotics Corp, acquired 11,107 shares of common stock and 9,810 stock options.
• The common stock was acquired at a price of $0.
• Following the transaction, Shiblaq directly owns 66,968 shares of common stock.
• The stock options have an exercise price of $60.6.
• 1/48th of the shares subject to the Stock Option shall vest monthly from the vesting commencement date of March 5, 2025, over a four year period, subject continued employment or service by the Reporting Person to the Issuer through the applicable vesting date.
• One-quarter of the RSUs shall vest on March 5, 2026, with one-sixteenth of the remaining RSUs vesting quarterly over 36 months, subject to the Reporting Person continuing as a service provider through such date.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a standard disclosure of stock and option acquisition by an executive. The acquisition itself can be seen as a mildly positive sign, but it's not a major event.

Positives

• The acquisition of shares and options by a high-ranking executive could be seen as a positive signal about the company's future prospects.

Industry Context

This Form 4 filing is a routine disclosure required by the SEC when company insiders trade in their own company's stock. It provides transparency to investors about the actions of key personnel.

Stakeholder Impact

• The transaction could have a minor positive impact on shareholder sentiment.

Key Dates